An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
Article in Nature Medicine (April 2024)
The most recent citing publications are shown below. View all 70 publications that cite this research output on Dimensions.
Article in Nature Medicine (April 2024)
Article in Exploration of Medicine (April 2024)
Article in Cell Chemical Biology (April 2024)